Article citationsMore>>

Wilhelm, S.M., Adnane, L., Newell, P., Villanueva, A., Llovet, J.M. and Lynch, M. (2008) Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Molecular Cancer Therapeutics, 7, 3129-3140. doi:10.1158/1535-7163.MCT-08-0013

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top